Charles River Laboratories International (CRL) FY2021 results: revenue $3.5 billion, up 21.1% on the year
Charles River Laboratories International, Inc. (CRL) reported revenue of $3.5 billion for fiscal 2021, the year ended 25 December 2021, up 21.1% on the year before. Net income was $391 million, up 7.3%, and diluted earnings per share $7.60. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2022.
Revenue
$3.5 billion
+21.1% on the year
FY2014FY2021
Operating margin
16.7%
14.8% a year earlier
FY2014FY2021
Net income
$391 million
+7.3% on the year
FY2014FY2021
Diluted EPS
$7.60
+5.6% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
761
547
481
+39.2%
Capital expenditure
229
167
141
+37.4%
Free cash flow
532
380
340
+40.0%
Free cash flow margin
15.0%
13.0%
13.0%
Cash from investing
-1,438
-602
-682
Cash from financing
673
47.2
232
+1,323.5%
Depreciation and amortisation
266
235
198
+13.0%
Share-based compensation
71.5
56.3
57.3
+26.9%
Buybacks
40.7
24.0
18.1
+69.8%
Diluted shares, weighted
51m
51m
50m
+1.6%
Shares outstanding at period end
50m
50m
49m
+1.4%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
2,535
2,115
1,635
+19.9%
Non-controlling interest
4.2
3.6
3.2
+16.7%
Redeemable equity
53.0
25.5
28.6
+107.9%
Debt
2,664
1,980
1,888
+34.5%
Operating lease liabilities
253
156
116
+62.6%
Finance lease liabilities
24.5
26.0
27.5
-5.8%
Other liabilities
1,491
1,186
994
+25.8%
Total liabilities and equity
7,024
5,491
4,693
+27.9%
Fixed assets
1,291
1,124
1,044
+14.8%
Goodwill
2,712
1,809
1,541
+49.9%
Intangible assets
1,061
788
689
+34.7%
Investments
1.1
1.0
0.9
+3.8%
Cash and equivalents
241
228
238
+5.6%
Receivables
643
618
514
+4.1%
Inventory
199
186
161
+7.2%
Other assets
876
737
505
+18.9%
Total assets
7,024
5,491
4,693
+27.9%
10-K for the year ended 25 December 2021, filed 16 February 2022: the filing.